Some studies have shown that the expression of serum S100A9 is upregulated in some cancers, such as breast cancer and pancreatic cancer 11; many other studies have found significantly increased levels of serum S100A9 in inflammatory diseases, such as rheumatoid arthritis 22. Here, S100A9 is linked to familial pancreatic carcinoma.